Is M7T.AX overvalued or undervalued?

M7T.AX currently has a P/E ratio of -5.66. Relative to the sector average of 41.10, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy Mach7 Technologies Limited stock?

Mach7 Technologies Limited trades on ASX. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of M7T.AX?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying M7T.AX protect my money against local inflation?

Many investors in Latin America buy international stocks like M7T.AX to protect their purchasing power. Because M7T.AX is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy M7T.AX shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is M7T.AX a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well M7T.AX diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocksM7T.AX

Mach7 Technologies Limited

A$0.22-A$0.01-2.27%

ASX / AUD

Market cap

A$51M

P/E

-5.7

EPS (TTM)

A$-0.03

Dividend yield

0.00%

Beta

1.06

1Y return

-27.12%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$19M2022

$20M2023

$11M2024

$22M2025

$19M2026

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.00Low
Current ratio1.84
Cash ratio1.39
Net margin-32.0%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

M7T.AX-5.7
Healthcare sector median41.1
S&P 50022.0

Trades about 114% below its sector, cheaper than its peers on earnings.

Ratios

PEG0.09
Price to book1.46
EPS (TTM)A$-0.03
Payout ratio0%
FCF yield-1.96%

Range & risk

A$0.21A$0.69

Trading in the lower third of its 52-week band

Beta1.06

Profile

What Mach7 Technologies Limited actually does

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients’ medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists’ workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.

CEO

Teri Thomas

Employees

167

Headquarters

Melbourne, VIC

Founded

2005-11-28

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save M7T.AX and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

M7T.AX has a beta of 1.06, which indicates how sensitive it has historically been to movements in its broader market. A beta above 1 suggests higher relative volatility than the market. Beta is based on historical data and does not predict future performance.

Mach7 Technologies Limited